Last 353.70 GBp
Change Today -1.70 / -0.48%
Volume 322.7K
UDG On Other Exchanges
As of 5:00 AM 08/1/14 All times are local (Market data is delayed by at least 15 minutes).

udg healthcare plc (UDG) Snapshot

350.70 GBp
Previous Close
355.40 GBp
Day High
355.40 GBp
Day Low
350.70 GBp
52 Week High
02/27/14 - 380.10 GBp
52 Week Low
11/25/13 - 293.30 GBp
Market Cap
Average Volume 10 Days
0.11 GBp
Shares Outstanding
0.10 GBp
Dividend Yield
Current Stock Chart for UDG HEALTHCARE PLC (UDG)

Related News

No related news articles were found.

udg healthcare plc (UDG) Related Businessweek News

No Related Businessweek News Found

udg healthcare plc (UDG) Details

UDG Healthcare plc, together with its subsidiaries, provides supply chain, packaging, medical, regulatory, and sales and marketing services to healthcare manufacturers and pharmacies operating in the Republic of Ireland, the United Kingdom, North America, and continental Europe. It operates through three segments: Supply Chain Services, Sharp Packaging Services, and Ashfield Commercial & Medical Services. The company offers integrated logistics and associated commercial services for pharmaceutical, biotech, and consumer companies in the areas of pharma wholesale, as well as bulk and medicine distribution. It also provides clinical and commercial packaging, storage, logistics, and project management services to the pharmaceutical and biotech industry. In addition, the company offers a range of outsourced solutions to pharmaceutical and biotech companies, including sales and marketing, healthcare communications, event management, medical affairs, and regulatory services. Further, it distributes specialist healthcare and scientific products and services, as well as provides outsourced sales, marketing, distribution, and engineering services to its clients. The company was formerly known as United Drug plc and changed its name to UDG Healthcare plc in August 2013. UDG Healthcare plc was founded in 1948 and is based in Dublin, Ireland.

8,000 Employees
Last Reported Date: 01/6/14
Founded in 1948

udg healthcare plc (UDG) Top Compensated Officers

Chief Executive Officer, Director and Member ...
Total Annual Compensation: €684.0K
Chief Financial Officer and Executive Directo...
Total Annual Compensation: €435.0K
Managing Director of Ashfield Commercial & Me...
Total Annual Compensation: €412.0K
Compensation as of Fiscal Year 2013.

udg healthcare plc (UDG) Key Developments

UDG Healthcare plc Presents at Jefferies 2014 Global Healthcare Conference, Jun-04-2014 03:00 PM

UDG Healthcare plc Presents at Jefferies 2014 Global Healthcare Conference, Jun-04-2014 03:00 PM. Venue: Grand Hyatt, New York, New York, United States. Speakers: Alan Ralph, Chief Financial Officer and Executive Director.

UDG Healthcare plc Announces Unaudited Consolidated Earnings Results for the Six Months Ended March 31, 2014; Revised Earnings Guidance for the Full Year of 2014; Declares Interim Dividend Payable on July 17, 2014

UDG Healthcare plc announced unaudited consolidated earnings results for the six months ended March 31, 2014. For the period, the company announced revenue of EUR 1,041,373,000 compared to EUR 1,017,389,000 for the same period a year ago. Operating profit was EUR 25,188,000 compared to EUR 24,147,000 for the same period a year ago. Profit before tax was EUR 17,191,000 compared to EUR 17,310,000 for the same period a year ago. Profit attributable to owners of the parent company was EUR 11,870,000 compared to EUR 12,741,000 for the same period a year ago. Earnings per share, diluted were 4.91 cents compared to 5.30 cents for the same period a year ago. Net cash inflow from operating activities was EUR 8,565,000 compared to EUR 55,752,000 for the same period a year ago. Purchase of property, plant and equipment was EUR 16,068,000 compared to EUR 23,923,000 for the same period a year ago. Earnings adjusted for amortisation of acquired intangible assets, acquisition costs and exceptional items was EUR 29,953,000 compared to EUR 29,833,000 for the same period a year ago. Adjusted earnings per share, diluted were 12.38 cents compared to 12.42 cents for the same period a year ago. Net debt at 31 March 2014 increased to EUR 338 million. Underlying EPS up 10% on the same period in 2013 when one-off impacts of re-branding and the carrying costs of increased financing are excluded. Adjusted operating profit was EUR 45 million, adjusted profit after tax was EUR 30 million or 12.38 cents per adjusted diluted share. For the full year, EPS guidance increased from a growth range of 2% - 5% to 5% - 9%, following the KnowledgePoint360 acquisition. The Board of Directors has declared an interim dividend of 2.69 cent per share, a 3% increase on the 2013 interim dividend. The interim dividend is payable to shareholders on the company's register at 5.00 p.m. on 23 May 2014 and will be paid on 17 July 2014.

UDG Healthcare plc, H1 2014 Earnings Call, May 14, 2014

UDG Healthcare plc, H1 2014 Earnings Call, May 14, 2014


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
UDG:LN 353.70 GBp -1.70

UDG Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cardinal Health Inc $71.65 USD -1.10
Celesio AG €25.58 EUR +0.025
CMIC Holdings Co Ltd ¥1,999 JPY +55.00
EPS Corp/Japan ¥1,397 JPY +7.00
Galenica AG SFr.820.00 CHF -8.00
View Industry Companies

Industry Analysis


Industry Average

Valuation UDG Industry Range
Price/Earnings 38.6x
Price/Sales 0.5x
Price/Book 2.6x
Price/Cash Flow 38.7x
TEV/Sales 0.5x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact UDG HEALTHCARE PLC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at